Gene biomarkers for prediction of susceptibility of ovarian neoplasms and/or prognosis or malignancy of ovarian cancers

研究成果: 雜誌貢獻文章同行評審

摘要

The disclosure provides methylome analysis using DNA methylation biomarkers for predicting ovarian cancer prognosis and detecting malignant ovarian cancer. Being independent prognostic factors for patients with current treatment protocols, these DNA methylations are also important biomarkers for treating patients with individualized medicine in future including using chemotherapy, especially the demethylation agents or other epigenetic drugs.
原文???core.languages.zh_TW???
期刊US Patent App
出版狀態已發佈 - 三月 7 2013
對外發佈

引用此